Brief: Hansa Biopharma Says Intends To Carry Out Directed Share Issue Of Approximately 10 Million Shares
18/06/2025 16:37
June 18 (Reuters) - Hansa Biopharma AB HNSA.ST: HANSA BIOPHARMA INTENDS TO CARRY OUT DIRECTED SHARE ISSUE OF APPROXIMATELY 10 MILLION SHARES AND HAS ENTERED INTO NON-BINDING TERMS WITH NOVAQUEST TO RESTRUCTURE DEBT Source text: ID:nWkr6vh6sV Further company coverage: HNSA.ST ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hansa Biopharma AB
See all newsBrief: Hansa Biopharma Q3 Rev Up At SEK 143 Mln
Sweden's Hansa Biopharma Q3 revenue surges on SERB license deal
Brief: Hansa Biopharma Q3 Net Income SEK -178.5 Million
Brief: Hansa Biopharma Announces Positive Idefirix Paes Results Presented In The High-Impact Clinical Trials Session At Asn Kidney Week
Brief: Hansa Biopharma Submits IND Application To FDA For HNSA-5487 In GBS